bioAffinity Technologies, Inc.'s total assets for Q3 2025 were $11.55M, an increase of 143.03% from the previous quarter. BIAF total liabilities were $2.64M for the fiscal quarter, a -61.61% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.